News Home Page
Access the 15 most recent news items below. For older items, please click the 'view archives' link in the lower right.
New Research Reinforces Early Introduction of Peanuts to Prevent Peanut Allergies
Most children previously enrolled in a pivotal peanut allergy prevention study in which they were introduced to peanut early in life continued to tolerate peanuts, even after avoiding peanuts for a full year, according to the results of the LEAP-On Study. Funded by Food Allergy Research & Education (FARE) and the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, the study was presented recentlyy at the annual scientific meeting of the American ...
Posted on: May 30, 2016
Onset Introduces New InTemp Product Line for Pharmaceutical Cold Chain Monitoring
Shifting the temperature just a few degrees higher or lower can render a vaccine ineffective. This potentially leads to millions in lost revenue-and worse, a loss of trust among consumers as word spreads about the need to revaccinate. Onset, a world leader in data loggers, is addressing this challenge with the debut of the InTemp CX400 Series pharmaceutical cold chain management (CCM) products.The new InTemp CX400 Series is the first pharmaceutical cold chain monitoring solution that combines Bluetooth ...
Posted on: May 29, 2016
Bio-Rad Announces Digital PCR Instrument With the CE IVD Mark
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) recently announced CE IVD marking for its QX200 Droplet Digital PCR (ddPCR) System, the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic (IVD) in the European Union.With the CE IVD mark, medical practitioners in Europe can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to transplant rejection and ...
Posted on: May 28, 2016
Next-Generation Immunotherapy Offers New Hope for Brain Cancer
High-grade glioma is the most aggressive form of brain cancer. Despite improvements in surgical procedures, chemotherapy, and radiotherapy, this type of brain tumour is still notoriously hard to treat: less than 10% of patients survive beyond five years. Researchers from KU Leuven, Belgium, have now shown that next-generation cell-based immunotherapy may offer new hope in the fight against brain cancer. Their findings were published in Science Translational Medicine. Cell-based immunotherapy involves the ...
Posted on: May 27, 2016
Clearpath Derm Brings Digital Pathology to Dermatologists
Clearpath Derm, a company founded by Dermpath Lab of Central States (DLCS), a full-service dermatopathology laboratory that has been serving physicians for over 30 years, recently announced the launch of Clearpath 3.0, a digital software solution for dermatopathology. Clearpath 3.0 provides dermatologists with real-time access to whole slide images and patient case information from anywhere using a tablet, iPad or computer. The Clearpath solution leverages images from the Aperio ePathology whole slide ...
Posted on: May 26, 2016
Horizon Discovery and Centauri Therapeutics Enter Immuno-Oncology Therapeutic Development
Horizon Discovery Group plc (LSE: HZD), the leading international gene editing company, announced recently that it has formed an immune-oncology joint venture, Avvinity Therapeutics, with Centauri Therapeutics Limited, a UK-based biotechnology company focused on the discovery and development of novel molecules targeting life-threatening infectious diseases. This transaction represents part of Horizon's previously outlined strategy to invest up to £10 million, further leveraged by its IP, technology ...
Posted on: May 25, 2016
New Paper on Shortening Timelines for Bioprocessing
Sartorius Stedim Biotech (SSB) recently announced that a new paper, titled Shortening Timelines for Upstream Bioprocessing of Protein-based Therapeutics, has been published in the journal, BioPharma Asia. The paper details how scientists at leading Asian pharmaceutical company, WuXi AppTec, are using the ambr 15 automated micro bioreactor system to mimic bench-top and production scale bioreactors, producing comparable results with cell growth, cell metabolism and protein production, including similar ...
Posted on: May 24, 2016
BioFire Receives FDA Clearance for FilmArrayTorch
BioMérieux, a world leader in the field of in vitro diagnostics,recently announced that BioFire Diagnostics, LLC, its molecular biology affiliate, has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market the FilmArray Torch for use with the FilmArray Respiratory Panel (RP), and has submitted special 510(k) applications for use with additional FilmArray panels , including blood culture identification, gastrointestinal and meningitis/encephalitis panels. BioFire ...
Posted on: May 23, 2016
International Cancer Genome Consortium Reaches 1,000 User Milestone
The International Cancer Genome Consortium (ICGC) announced recently that its Data Access Compliance Office (DACO) authorized its 1,000th user, giving them access to the Consortium's Controlled Access datasets. This means that more authorized researchers than ever before are accessing ICGC's Controlled Access data for their research and using these datasets as the foundation for the next generation of cancer diagnostics and treatments.ICGC datasets that catalogue tumor-specific mutations are unrestricted ...
Posted on: May 22, 2016
New Mechanism of Neurodegeneration Leads to a Novel Treatment for Alzheimer's Disease
Neuro-Bio Limited, a biotech company founded by world-renowned neuroscientist Professor Susan Greenfield to explore novel therapeutics and diagnostics for neurodegenerative disorders, described recently in the peer-reviewed journal, Neuropharmacology, a new model for the mechanism of neurodegeneration leading to Alzheimer's disease and its potential for new treatments.Alzheimer's is characterized by, amongst other factors, the presence of amyloid in its various forms and hyperphosphorylated tau, leading ...
Posted on: May 21, 2016
Study Calls into Question Current MERS Vaccine Strategy
A recent study suggests that the Middle East Respiratory Syndrome coronavirus (MERS-CoV) develops mutations that make the virus less virulent during an outbreak rather than more virulent. The study, published in mBio, an online open-access journal of the American Society for Microbiology, has implications for vaccine development.MERS-CoV causes severe respiratory infection and has a worldwide mortality rate of approximately 35%. Similar to other coronaviruses, MERS-CoV utilizes a large surface spike ...
Posted on: May 20, 2016
Irvine Scientific Launches New Feed Media
Irvine Scientific, a leading specialist in cell culture media development, recently announced the launch of BalanCD CHO Feed 4, a chemically-defined, animal component-free powder feed for large-scale bioproduction in a variety of high performing CHO cells. When paired with BalanCD CHO Growth A in fed-batch culture systems, up to 20 million viable cells/mL, and antibody titer up to 6g/ L can be achieved.Recent developments in cell line engineering have resulted in cell lines capable of reaching higher cell ...
Posted on: May 19, 2016
Verseon Presents Low Bleeding Risk Anticoagulants
New preclinical data for a promising class of oral anticoagulants was presented by Verseon Corporation (AIM: VSN) to delegates at the 3rd International Conference on Heart & Brain (ICHB) in Paris recently. The data conclusively demonstrates the effectiveness of Verseon's novel, highly selective direct thrombin inhibitors (DTIs) as a potential treatment for arterial thrombotic disorders with a lower bleeding risk than current anticoagulants.The new results build upon other preclinical data, presented ...
Posted on: May 18, 2016
Bio-Rad Announces CE IVD Marking of Its System for Use as an In Vitro Diagnostic
Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) recently announced CE IVD marking for its QX200™ Droplet Digital™ PCR (ddPCR™) System, the first digital PCR system with the CE IVD mark for use as an in vitro diagnostic (IVD) in the European Union. With the CE IVD mark, medical practitioners in Europe can use the QX200 system for highly-accurate detection and quantification of nucleic acids, aiding clinical decision-making in the treatment of diseases ranging from cancer to ...
Posted on: May 17, 2016
Big Cities Health Coalition Urges Congress to Pass Zika Emergency Funding
The Big Cities Health Coalition (BCHC) recently called on Congress to pass the President's $1.8 billion emergency funding request designed to prepare for and respond to the Zika virus. The Coalition membership consists of the 28 largest public health departments in the United States, representing 1 in 6 Americans. Many of these local health departments are engaged in educating the public and health care providers about Zika, conducting prevention activities through mosquito eradication, and screening ...
Posted on: May 16, 2016